The Most Common Chronic Liver Disease in the World
Global Liver Institute on the Road
Last month, the GLI team proudly attended AASLD’s The Liver Meeting™, starting with our 10th anniversary celebration, which brought together patient advocates, industry leaders, and liver community members to celebrate a decade of impactful work. Through the rest of the meeting, GLI team members engaged in key discussions and panels including “Lifestyle Management of MASLD: Challenges and Opportunities” to “Sharing the Patient & Caregiver Perspective on Acute-on-Chronic Liver Failure.” GLI Ambassadors, A3 alumni, and other members of the GLI community also shared their expertise in various panels and presentations. Following the meeting, members from the Liver Action Network gathered to celebrate year-end accomplishments and reignite excitement for the year ahead. It was an inspiring series of days filled with valuable insights and passionate advocacy.
Galien Foundation’s 2024 Galien Forum
Jeff McIntyre, VP of Liver Health Programs at GLI, contributed to the Galien Foundation’s 2024 Galien Forum in New York City, where he participated in engaging discussions alongside Nobel Laureates, policymakers, and industry leaders. As the sole patient representative, he joined the “From NASH to MASH” panel, which explored promising diagnostic and treatment approaches for MASH.
NCQA Health Innovation Summit
Jeff McIntyre also represented GLI at the NCQA Health Innovation Summit in Nashville, Tennessee. He participated in the “MASH Matters” panel alongside Drs. Meena Bansal and Rena Kramer Fox to discuss the critical intersection of primary care, liver specialty care, and patient advocacy in raising awareness about MASH and its broad impact on patients and society.
Emerging Insights
The Most Common Chronic Liver Disease in the World
The Curbsiders Podcast recently discussed MASLD in an accessible and conversational format, covering streamlined diagnostic approaches like the FIB-4 score and noninvasive tests such as elastography to assess liver fibrosis. They emphasized the therapeutic benefit of weight loss in reversing liver damage and introduced resmetirom, a recently approved drug shown to reduce fibrosis.
Association of Depression with Severe NAFLD
A large-scale UK Biobank study found that depression is associated with an increased risk of severe NAFLD, with further genetic analysis supporting this link. These findings highlight the importance of mental health in preventing and managing liver disease and suggest that monitoring for NAFLD in patients with depression could be beneficial.
⬇️ Education Resources Available ⬇️
GLI is proud to offer a range of continuing education programs to support healthcare providers in expanding their knowledge and skills in MASLD and MASH. These programs provide valuable CE credits and are available until June 2025. Explore our educational resources below to enhance your expertise in these critical areas.
Endocrinologists and PCPs: The Frontline Defense Against Cirrhosis in Patients with Type 2 Diabetes
Through a partnership with the Global Learning Collaborative, GLI now offers this continuing education course on ReachMD. This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
Build Your Own Case Study | Redefining MASLD/MASH Care: Personalized Strategies for Assessment, Diagnosis and Management
In collaboration with the Medical Learning Institute, GLI presents an interactive course to Build Your Own Case Study. Health Care Providers in the endocrinology specialty setting are challenged to be knowledgeable of the pathophysiology of MASLD and MASH and its associated risk factors, as well as feel confident about how and when to order noninvasive diagnostic tests to prevent the emergence of more severe complications and stay on top of current guidelines and emerging treatment options.
Upcoming Events
- December 5, 2024: Third Annual Primary Care MASLD/MASH Summit – virtual, co-hosted by Fatty Liver Alliance and CanNASH
Join us at our next Fatty Liver Disease Council Meeting on Thursday, December 19, 2024. For more info, visit globalliver.org/fatty-liver-disease-council or email fattyliverdisease@globalliver.org.
